Delisting riskPopularity #4,500
Sunshine Biopharma (SBFM)
Commercializer of Canadian generic medicines with early-stage oncology and antiviral research.
$0.9114
vs last close+0.01 (+0.56%)
Something off on this page? Send us feedback.
Next report
Nov 12, 26
estimated · in 50 days
EPS estimate
−$0.17
Revenue estimate
$9.6M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Apr '26May '26Aug '26Nov '26
Reported−$10.10−$4.40−$3.90−$1.90−$3.00−$2.50−$1.15Pending
Estimate$0.10—−$1.10−$1.30−$2.70−$2.50−$1.20−$0.17
Surprise−10,200.0%—−254.5%−46.2%−11.1%0.0%+4.2%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Apr '26May '26Aug '26Nov '26
Reported$9.6M$8.9M$9.4M$9.4M$8.6M$8.1M$9.3MPending
Estimate$12.5M—$11.2M$11.1M$10.0M$8.1M$8.7M$9.6M
Surprise−23.2%—−16.0%−15.2%−14.0%0.0%+6.9%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2026 | −$0.29 | — | — |
| Nov 2026 | −$0.17 | — | — |
| Aug 2026 | −$1.20 | −$1.15 | +4.2% |
| May 2026 | −$2.50 | −$2.50 | 0.0% |
| Apr 2026 | −$2.70 | −$3.00 | −11.1% |
| Nov 2025 | −$1.30 | −$1.90 | −46.2% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Apr 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Apr 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Apr 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Apr 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Apr 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Aug 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2026 | −$0.29 | — | — | $9.8M | — | — | — |
| Nov 12, 2026 | −$0.17 | — | — | $9.6M | — | — | — |
| Aug 13, 2026 | −$1.20 | −$1.15 | +4.2% | $8.7M | $9.3M | +6.9% | −0.8% |
| May 13, 2026 | −$2.50 | −$2.50 | 0.0% | $8.1M | $8.1M | 0.0% | −28.9% |
| Apr 3, 2026 | −$2.70 | −$3.00 | −11.1% | $10.0M | $8.6M | −14.0% | +11.5% |
| Nov 13, 2025 | −$1.30 | −$1.90 | −46.2% | $11.1M | $9.4M | −15.2% | −2.4% |
| Aug 12, 2025 | |||||||
| May 15, 2025 | |||||||
| Mar 31, 2025 | |||||||
| Nov 5, 2024 | |||||||
| Aug 19, 2024 | |||||||
| May 20, 2024 | |||||||
| Mar 28, 2024 | |||||||
| Nov 13, 2023 | |||||||
| Aug 11, 2023 | |||||||
| May 10, 2023 | |||||||
| Apr 4, 2023 | |||||||
| Nov 7, 2022 | |||||||
| Aug 3, 2022 | |||||||
| May 6, 2022 | |||||||
| Mar 21, 2022 | |||||||
| Nov 9, 2021 | |||||||
| Aug 9, 2021 | |||||||
| May 11, 2021 | |||||||
| Mar 30, 2021 | |||||||
| Nov 11, 2020 | |||||||
| Aug 19, 2020 | |||||||
| May 18, 2020 | |||||||
| Apr 30, 2020 | |||||||
| Nov 13, 2019 | |||||||
| Aug 15, 2019 | |||||||
| May 20, 2019 | |||||||
| Apr 12, 2019 | |||||||
| Nov 16, 2018 | |||||||
| Aug 17, 2018 | |||||||
| May 21, 2018 | |||||||
| Apr 2, 2018 | |||||||
| Nov 15, 2017 | |||||||
| Aug 11, 2017 | |||||||
| May 12, 2017 | |||||||
| Apr 17, 2017 | |||||||
| Nov 14, 2016 | |||||||
| Aug 16, 2016 | |||||||
| May 9, 2016 | |||||||
| Mar 25, 2016 | |||||||
| Nov 4, 2015 | |||||||
| Aug 6, 2015 |